Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 1
1993 1
1994 1
1995 1
1996 2
1997 1
1998 3
1999 2
2000 6
2001 2
2002 3
2003 8
2004 3
2005 3
2006 6
2007 5
2008 7
2009 4
2010 3
2011 10
2012 12
2013 18
2014 16
2015 22
2016 28
2017 25
2018 35
2019 19
2020 9
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 27797895

235 results
Results by year
Filters applied: . Clear all
Page 1
Viral-Associated GN: Hepatitis C and HIV.
Kupin WL. Kupin WL. Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1337-1342. doi: 10.2215/CJN.04320416. Epub 2016 Oct 24. Clin J Am Soc Nephrol. 2017. PMID: 27797895 Free PMC article. Review.
Viral-Associated GN: Hepatitis B and Other Viral Infections.
Kupin WL. Kupin WL. Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1529-1533. doi: 10.2215/CJN.09180816. Epub 2016 Oct 18. Clin J Am Soc Nephrol. 2017. PMID: 27797900 Free PMC article. Review.
Prevalence of hepatitis B and C markers in glomerular diseases.
Enríquez R, Rodríguez JC, Sirvent AE, Amorós F, Ardoy F, Alvarez M, Royo G. Enríquez R, et al. Scand J Urol Nephrol. 2007;41(6):535-8. doi: 10.1080/00365590701365131. Scand J Urol Nephrol. 2007. PMID: 17853005
HIV and hepatitis C coinfection.
Matthews GV, Dore GJ. Matthews GV, et al. J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1000-8. doi: 10.1111/j.1440-1746.2008.05489.x. J Gastroenterol Hepatol. 2008. PMID: 18707597 Review.
HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.
Papasavvas E, Azzoni L, Yin X, Liu Q, Joseph J, Mackiewicz A, Ross B, Lynn KM, Jacobson JM, Mounzer K, Kostman JR, Montaner LJ. Papasavvas E, et al. J Viral Hepat. 2017 Oct;24(10):865-876. doi: 10.1111/jvh.12714. Epub 2017 May 11. J Viral Hepat. 2017. PMID: 28419653 Free PMC article.
Higher Activation in CD4(+) T Cells But Similar Viral Control Among HIV/Hepatitis C Virus-Coinfected Patients on a Simplification Monotherapy.
BenMarzouk-Hidalgo OJ, Torres-Cornejo A, Gutierrez-Valencia A, Ruiz-Valderas R, Viciana P, López-Cortés LF. BenMarzouk-Hidalgo OJ, et al. AIDS Res Hum Retroviruses. 2016 Jan;32(1):6-11. doi: 10.1089/AID.2014.0299. Epub 2015 Oct 21. AIDS Res Hum Retroviruses. 2016. PMID: 26414169
Transient liver injury associated with the early recovery of HCV-specific T-cell responses and HCV rebound in HIV-1/HCV coinfected patients undergoing highly active antiretroviral therapy.
Kang F, Chen W, Zhang X, Nie W, Fu J, Xu X, Zhao P, Zhang X, Li W, Wang FS, Zhang Z, Zhao M. Kang F, et al. J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):135-42. doi: 10.1097/QAI.0b013e3182752d20. J Acquir Immune Defic Syndr. 2013. PMID: 23075912
During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.
Kostadinova L, Shive CL, Judge C, Zebrowski E, Compan A, Rife K, Hirsch A, Falck-Ytter Y, Schlatzer DM, Li X, Chance MR, Rodriguez B, Popkin DL, Anthony DD. Kostadinova L, et al. J Infect Dis. 2016 Nov 1;214(9):1438-1448. doi: 10.1093/infdis/jiw372. Epub 2016 Aug 17. J Infect Dis. 2016. PMID: 27540113 Free PMC article.
235 results
Jump to page
Feedback